iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares RENUKA INE087H01022 Cancellation 2023-05-12 2023-05-12 true 2023-03-31 2023-06-01 Financial results Audited Standalone And Consolidated Yearly March 2023 Pursuant to Regulation 29 and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our announcement dated 3rd May 2023 regarding intimation of Board meeting date, we wish to inform that a separate meeting of the Board of Directors will be convened to consider and approve Audited Financial Results (Standalone & Consolidated), for the quarter and year ended 31st March 2023. The Board meeting scheduled on Friday, 12th May 2023 will be held as per schedule to consider and approve the other business matters. The date of the Board meeting to consider Audited Financial Results (Standalone & Consolidated), for the quarter and year ended 31st March 2023 will be informed to you separately. Further, pursuant to the Company’s ‘Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of trading by Insiders’ the ‘Trading Window’ for trading in the Company's equity shares by the Specified Persons shall continue to remain closed till the expiry of 48 hours after disclosure of financial results for the quarter and year ended 31st March 2023 to the Stock Exchanges. For XBRL filing purpose, the trading window end date is mentioned as 1 June 2023. The actual trading window date will be informed to you along with revised Board Meeting date.